- Home
- Publications
- Publication Search
- Publication Details
Title
Antiviral Activities of Silymarin and Derivatives
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 8, Pages 1552
Publisher
MDPI AG
Online
2019-04-22
DOI
10.3390/molecules24081552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress
- (2018) Fernanda Caetano Camini et al. ANTIVIRAL RESEARCH
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
- (2018) Frederick G. Hayden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies
- (2017) Nouman Rasool et al. JOURNAL OF VECTOR BORNE DISEASES
- Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
- (2017) Alessandro Federico et al. MOLECULES
- Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)—Chemistry, Bioavailability, and Metabolism
- (2017) Michal Bijak MOLECULES
- Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
- (2016) Giulia Malaguarnera et al. BMC Psychiatry
- Highly bioavailable silibinin nanoparticles inhibit HCV infection
- (2016) Ching-Hsuan Liu et al. GUT
- Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy
- (2016) S. DebRoy et al. JOURNAL OF VIRAL HEPATITIS
- A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
- (2015) Dominique L. Braun et al. PLoS One
- Antiviral activity of silymarin against chikungunya virus
- (2015) Rafidah Lani et al. Scientific Reports
- Continuing challenges in influenza
- (2014) Robert G. Webster et al. Annals of the New York Academy of Sciences
- Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients
- (2014) DL Braun et al. HIV MEDICINE
- Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics
- (2014) Harel Dahari et al. LIVER INTERNATIONAL
- Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells
- (2014) Nitesh Kumar et al. Pharmacological Reports
- Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial
- (2014) Maria Rendina et al. TRANSPLANT INTERNATIONAL
- Identification of 23-(S)-2-Amino-3-Phenylpropanoyl-Silybin as an Antiviral Agent for Influenza A Virus InfectionIn VitroandIn Vivo
- (2013) Jian-Ping Dai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking
- (2013) Julie Blaising et al. CELLULAR MICROBIOLOGY
- Analysis of hepatitis C virus resistance to silibininin vitroandin vivopoints to a novel mechanism involving nonstructural protein 4B
- (2013) Katharina Esser-Nobis et al. HEPATOLOGY
- Inhibition of HIV by Legalon-SIL is independent of its effect on cellular metabolism
- (2013) Janela McClure et al. VIROLOGY
- Preparation and Pharmacological Evaluation of Silibinin Liposomes
- (2012) Hitesh Maheshwari et al. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
- Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection
- (2012) Alessio Aghemo et al. Hepatitis Monthly
- Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection
- (2012) Stephen J. Polyak et al. HEPATOLOGY
- Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy
- (2012) Michael W. Fried JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Understanding silibinin’s modes of action against HCV using viral kinetic modeling
- (2012) Jeremie Guedj et al. JOURNAL OF HEPATOLOGY
- Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period
- (2012) Rafael Bárcena et al. JOURNAL OF HEPATOLOGY
- Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period
- (2012) Zoe Mariño et al. JOURNAL OF HEPATOLOGY
- Characteristics and Antioxidant Activities of Silymarin Nanoparticles
- (2012) Wen-Chan Hsu et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation
- (2012) Janela McClure et al. PLoS One
- Intravenous silibinin as ‘rescue treatment’ for on-treatment non-responders to pegylated interferon/ribavirin combination therapy
- (2011) Karoline Rutter et al. ANTIVIRAL THERAPY
- High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy
- (2011) M. Biermer et al. JOURNAL OF VIRAL HEPATITIS
- Silymarin efficacy against influenza A virus replication
- (2011) J.H. Song et al. PHYTOMEDICINE
- Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation
- (2011) Jessica Wagoner et al. PLoS One
- Silybin and the liver: From basic research to clinical practice
- (2011) Carmela Loguercio WORLD JOURNAL OF GASTROENTEROLOGY
- First Report of Sylvatic DENV-2-Associated Dengue Hemorrhagic Fever in West Africa
- (2011) Leticia Franco et al. PLoS Neglected Tropical Diseases
- Development of Silymarin Self-Microemulsifying Drug Delivery System with Enhanced Oral Bioavailability
- (2010) Xinru Li et al. AAPS PHARMSCITECH
- Multiple effects of silymarin on the hepatitis C virus lifecycle
- (2010) Jessica Wagoner et al. HEPATOLOGY
- Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV–HCV coinfected patient
- (2010) B.A. Payer et al. JOURNAL OF CLINICAL VIROLOGY
- Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy
- (2010) U.P. Neumann et al. JOURNAL OF HEPATOLOGY
- Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C
- (2010) Sandra Beinhardt et al. JOURNAL OF HEPATOLOGY
- In vitroandin vivoevaluation of silybin nanosuspensions for oral and intravenous delivery
- (2010) Yancai Wang et al. NANOTECHNOLOGY
- Identification of hepatoprotective flavonolignans from silymarin
- (2010) S. J. Polyak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antioxidant and antiviral activities of silybin fatty acid conjugates
- (2009) Radek Gažák et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rapid Suppression of Hepatitis C Viremia Induced by Intravenous Silibinin Plus Ribavirin
- (2009) Michael Biermer et al. GASTROENTEROLOGY
- Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase
- (2009) Abdelhakim Ahmed–Belkacem et al. GASTROENTEROLOGY
- Solid State Mechanochemical Activation of Silybum marianum Dry Extract With Betacyclodextrins: Characterization and Bioavailability of the Coground Systems
- (2009) D. Voinovich et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Chemopreventive Effect of Silymarin on Liver Pathology in HBV X Protein Transgenic Mice
- (2008) Y.-F. Wu et al. CANCER RESEARCH
- Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus
- (2008) Barbara Roe et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- Drug–drug interactions of silymarin on the perspective of pharmacokinetics
- (2008) Jhy-Wen Wu et al. JOURNAL OF ETHNOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More